ArticleInvestigative ophthalmology & visual science2026
T Cell-Derived IFN-γ Activates Ferroptosis in Lacrimal Luminal Ductal Cells via JAK-STAT Signaling in Sjögren's Disease-Related Dry Eye.
Article in Investigative ophthalmology & visual science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Sjögren's disease (SjD) leads to severe dry eye disease (DED) via lacrimal gland inflammation and dysfunction, yet the specific pathogenic mechanisms remain unclear. In this study, we aimed to deeply identify the vulnerable lacrimal epithelial subclusters and elucidate the immune-epithelial cross-talk. Methods: We used MRL/lpr mice as a murine SjD model and integrated bioinformatic analysis of single-cell RNA-sequencing (scRNA-seq) and spatial transcriptome datasets. These findings were validated using immunofluorescence (IF), multiplex immunohistochemistry analysis (mIHC), Western blot, transmission electron microscopy (TEM), and flow cytometry. Finally, an in vivo interferon-γ (IFN-γ) neutralization strategy was implemented, with therapeutic effects evaluated by the phenol red thread test and lissamine green staining. Results: ScRNA-seq and spatial analyses converged to identify luminal ductal epithelia (LDE), marked by CYP2F2, as the primary epithelial population damaged in SjD. This was further correlated with the specific upregulation of both Janus kinase/signal transducer and activator of transcription (JAK-STAT) signaling and ferroptosis pathway. We then confirmed that this periductal damage was driven by the infiltration of IFN-γ-secreting T helper 1 (Th1) cells. TEM analysis validated classical ferroptotic mitochondrial damage specifically in LDE. Systemic IFN-γ neutralization suppressed local Th1 infiltration, which in turn significantly downregulated the JAK2/STAT1 pathway and reversed ferroptosis within LDE. This intervention significantly alleviated DED signs, as evidenced by increased tear secretion and reduced corneal lissamine green staining. Conclusions: Our findings define a spatially-specific pathogenic axis where infiltrating Th1 cells release IFN-γ to trigger a JAK-STAT and ferroptosis cascade in LDE, highlighting IFN-γ neutralization as a promising therapeutic strategy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.